Records containing: Psoriasis
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2020-07-14Methotrexate Versus Secukinumab Safety in Psoriasis Patients With Metabolic Syndrome
-
CLINICAL_TRIALS study record update · 2020-07-07Study of the Association Between Work Stress and the Impact of Pruritus on Quality of Life
-
CLINICAL_TRIALS study record update · 2020-06-30Randomized, Double Blind, Placebo Controlled "First-in-human" Study to Assess the Safety and Tolerability of Single Ascending Oral Doses of PBF-1650 (40 mg, 80 mg, 120 and 240 mg) in Healthy Young Male Volunteers.
-
CLINICAL_TRIALS study record update · 2020-06-25A PHASE 1, RANDOMIZED, DOUBLE-BLIND, VEHICLE AND ACTIVE COMPARATOR-CONTROLLED, PSORIASIS PLAQUE TEST STUDY TO ASSESS SAFETY, TOLERABILITY, AND PSORIATIC SKIN INFILTRATE THICKNESS FOLLOWING REPEATED, TOPICAL DOSES OF PF-06763809 SOLUTION IN SUBJECTS WITH MILD TO MODERATE CHRONIC PLAQUE PSORIASIS
-
CLINICAL_TRIALS study record update · 2020-06-18A Randomized Clinical Trial to Determine Whether a Novel Plaque-based Dosimetry Strategy Can Improve the Speed of Response to Treatment in Patients With Plaque Psoriasis (Photos)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2020-06-12Post-Marketing Surveillance Study of Adalimumab (Humira) for Pediatric Chronic Severe Plaque Psoriasis Patients According to the Standard for "Re-Examination of New Drugs"
-
CLINICAL_TRIALS study record update · 2020-06-09The Anti-inflammatory Effects of Harkány Medicinal Water
-
CLINICAL_TRIALS study record update · 2020-05-14A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled Study Evaluating the Efficacy and Safety of CNTO 1959 (Guselkumab) in the Treatment of Subjects With Moderate to Severe Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2020-05-14Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
-
CLINICAL_TRIALS study record update · 2020-05-07A Phase 1, Multi-center, Randomized, Double-blind, Placebo-controlled, Multiple-dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CC-90006 Administered Subcutaneously in Patients With Plaque-type Psoriasis
-
CLINICAL_TRIALS study record update · 2020-05-04Open Label Study, Evaluating Taltz in Combination With Enstilar (Calcipotriene and Betamethasone Dipropionate) Foam in Psoriasis Patients
-
CLINICAL_TRIALS study record update · 2020-04-30Open Label Study Evaluating DUOBRII in Psoriasis Patients Being Treated With Biologic Agents.
-
CLINICAL_TRIALS study record update · 2020-04-27An Observational Study of the Real-life Management of Psoriasis Patients Treated With Otezla® (Apremilast) in Belgium
-
CLINICAL_TRIALS study record update · 2020-04-24Open-Label, Single-Arm Pilot Study to Evaluate the Pharmacodynamics, Pharmacokinetics, Safety, and Preliminary Efficacy of CC10004 in Subjects With Severe Plaque Type Psoriasis
-
CLINICAL_TRIALS study record update · 2020-04-24How Does Patients' Overall Assessment of Their Health Vary Across and Within Different Disease Groups? A Study Protocol to Study Health-related Quality of Life Using the EQ-5D in the Swedish National Quality Registers
-
CLINICAL_TRIALS study record update · 2020-04-24A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose Comparison Study of CC-10004 in Subjects With Moderate-to-Severe Plaque-Type Psoriasis
-
CLINICAL_TRIALS study record update · 2020-04-15A Single Center Study to Evaluate the Effectiveness and Safety of ILUMYA in Combination With HALOG Ointment 0.1% for the Treatment of Moderate to Severe Plaque Psoriasis.
-
CLINICAL_TRIALS study record update · 2020-04-14Serum Level of IL31,33 and 36 in Egyptian Paients With Psoriasis in Assiut University Hospital : Case Control Study
-
CLINICAL_TRIALS study record update · 2020-03-30Real-World Outcome of Psoriasis Patients in Korea on Adalimumab
-
CLINICAL_TRIALS study record update · 2020-03-20A Phase 2B, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Two Doses of Apremilast (CC-10004) In Japanese Subjects With Moderate-To-Severe Plaque-Type Psoriasis
-
CLINICAL_TRIALS study record update · 2020-03-19The Effect of BMS-986165 on the Pharmacokinetics of a Combined Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Subjects
-
CLINICAL_TRIALS study record update · 2020-03-18An Open-Label, Single-Sequence Study to Investigate the Effects of Cyclosporine on the Pharmacokinetics of BMS-986165 at Steady State in Healthy Male Participants
-
CLINICAL_TRIALS study record update · 2020-03-11An Outcomes Study to Determine the Reasons Patients on Biologic Therapy Discontinue Treatment and Fail to Follow-up With Their Providers
-
CLINICAL_TRIALS study record update · 2020-03-04Skin Tape Harvesting for Transcriptomics Analysis
-
CLINICAL_TRIALS study record update · 2020-02-25A Phase 1, Randomized, Open-Label, Single-Dose, Crossover Study To Evaluate the Bioavailability of BMS-986165 Tablet Formulation Relative To BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal And Increased Gastric pH on the Bioavailability of BMS-986165 Tablet Formulation in Healthy Subjects